Form D · Other Technology
Reliant Immune Diagnostics, Inc.
Austin, TX · CIK 0001770398
Offering snapshot reported Mar 20, 2019 · SEC filing
- Reported sold
- $10.9M Offering amount: $11.6M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Mar 5, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2019 | Initial | $10,875,092 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-335343
Source: Form D, filed Mar 20, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Deemer | Executive |
| Henry Joseph Legere Iii | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
6500 Riverplace Blvd. Building 4, Suite 102
Austin, TX, 78730
Austin, TX, 78730